Search All Jobs

Showing 1 of 1 Jobs

Engineer IV - Platform Infrastructure and SRE

Dallas, TX, USA

Full-Time

Engineer IV

Platform Infrastructure and SRE

Confirmed live in the last 24 hours

Omnicell

Omnicell

1,001-5,000 employees

Pharmacy care delivery and medication management solutions

No salary listed

Senior, Expert

Dallas, TX, USA

Category
DevOps & Infrastructure
Platform Engineering
Site Reliability Engineering
Required Skills
Datadog
Kubernetes
Grafana
Apache Kafka
Postgres
AWS
Elasticsearch
Prometheus
Terraform
Ansible
Linux/Unix
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Omnicell referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • Extensive experience with observation tooling such as Datadog, Prometheus, Grafana, AWS CloudWatch
  • Extensive experience with infrastructure deployment on AWS
  • Expert knowledge of Containerization
  • Experience with Kubernetes Administration
  • Experience with GitOps tools such as ArgoCD
  • Expert knowledge of Infrastructure automation tools such as Terraform or Ansible
  • Deep understanding of best practices for deploying, running and observing workloads in Kubernetes
  • Experience with one or more tools such as Kafka, Elasticsearch, NiFi, PostgreSQL
  • Expert in Linux administration
  • Experience within incident management processes
  • 8+ years of experience in software engineering
Responsibilities
  • Design and implement infrastructure to support Omnicell Cloud Platform
  • Implement & Manage an Effective Observability Strategy for Omnicell Cloud Platform & IoT devices
  • Automate delivery of platform services using infrastructure-as-a-code
  • Collaborate with application and business stakeholders to ensure high-quality product is developed and deployed in production
  • Design and implement CI/CD pipelines
Desired Qualifications
  • Experience with security scanning tools
  • Experience with intrusion detection systems

Omnicell focuses on improving the way pharmacy care is delivered in healthcare settings. The company offers a range of services that include central pharmacy management, IV compounding, point of care dispensing, and inventory optimization. These services utilize technology and expert knowledge to enhance medication management and connect different areas of care. What sets Omnicell apart from its competitors is its emphasis on integrating connected intelligence into its solutions, which helps address the changing needs of healthcare. The main goal of Omnicell is to optimize both financial and operational outcomes in pharmacy care.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Mountain View, California

Founded

1992

Simplify Jobs

Simplify's Take

What believers are saying

  • Omnicell's focus on data analytics optimizes specialty pharmacy operations.
  • OmniSphere aligns with the growing demand for cloud-based healthcare solutions.
  • Telepharmacy services expand Omnicell's reach in rural and underserved areas.

What critics are saying

  • Increased competition from major players in the specialty pharmacy market.
  • Challenges in achieving seamless data exchange and interoperability.
  • Potential financial risk from $172.5 million convertible senior notes issuance.

What makes Omnicell unique

  • Omnicell leverages AI and machine learning for enhanced medication management.
  • Omnicell's OmniSphere offers scalable, cloud-based solutions for medication management.
  • Collaboration with LSPedia enhances supply chain compliance and traceability.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Street Insider
Mar 24th, 2025
Omnicell (OMCL) appoints Perry Genova as CTO

Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, effective March 31, 2025.

MarketScreener
Mar 12th, 2025
Omnicell, Inc. Announces Step Down of Nchacha Etta as Executive Vice President Effective September 15, 2025

Omnicell, Inc. announced that Nchacha Etta will be stepping down from his role as Executive Vice President effective September 15, 2025 or until a successor is named.

Hit Consultant
Mar 4th, 2025
Data Is The Cure: Why Specialty Pharmacies Need Analytics To Thrive In 2024

Matt Manning, Sr. Director of Operations for Health Systems at OmnicellTo meet the rising demand for drugs to treat rare and chronic conditions, the industry’s largest players (e.g., CVS Health, Cigna, and UnitedHealth Group) have moved quickly to derive two-thirds of their prescription revenues from specialty dispensing. Health systems are following suit, rapidly launching entity-owned specialty pharmacies that enable these providers to strengthen the continuity of care they deliver to patients. As providers stake out claim in the competitive $68.3 billion specialty drug market, strategic application of data analytics to provide key fulfillment insights could be the differentiator that ensures success.Challenges Associated with Entity-Owned Specialty PharmaciesA fully optimized, entity-owned specialty pharmacy is a key way for health systems to improve patient care by increasing access to specialty medications and reducing the turnaround time for prescription fulfillment while at the same time generating revenue via increased script capture. However, challenges in key operational areas prevent health systems from realizing these benefits, including:Interoperability: As seamless data exchange remains the modern healthcare standard. Pharmacies with connectivity gaps suffer hits to patient experience and care coordination due to not having the most up-to-date information to influence patient onboarding, prescribing decisions, and patient communications.As seamless data exchange remains the modern healthcare standard

HR Tech Wire
Jan 14th, 2025
Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025

Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025

Keles Care
Jan 10th, 2025
David Buller - KELES Managing Partner

After scaling the company to 50 staff and annual revenues exceeding $10 million, Avantec was acquired by Omnicell (NASDAQ: OMCL) in 2015.